Amarin Corp Plc (AMRN)

[JRoon71]

Monk, what are you asking? There was essentially no difference between Vascepa and placebo. In fact, the placebo group actually did slightly better (which was not statistically significant).

IMO, the trial is too short, and I'm not even sure the outcome measures were appropriate. But in a short trial like this, it's all they could really measure.

As CaptBeer stated, I believe that EPA is effective over long periods of time, which is why populations with high fish intake have lower incidence of dementia. Vascepa is not an acute medication.

But outside of meta-analysis, I don't believe a long-term trial could ever be conducted like this. It would have to be VERY long, and it would have to start earlier in life.